Zongli Ding

543 total citations
18 papers, 386 citations indexed

About

Zongli Ding is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zongli Ding has authored 18 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Cancer Research and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zongli Ding's work include RNA modifications and cancer (6 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (4 papers). Zongli Ding is often cited by papers focused on RNA modifications and cancer (6 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (4 papers). Zongli Ding collaborates with scholars based in China. Zongli Ding's co-authors include Yulong Zheng, Zeyi Liu, Jian‐An Huang, Jianjie Zhu, Yuanyuan Zeng, Wenwen Du, Wei Wang, Tao Li, Wan Yu and Haicheng Tang and has published in prestigious journals such as Frontiers in Immunology, Cell Death and Disease and Biomedicine & Pharmacotherapy.

In The Last Decade

Zongli Ding

17 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zongli Ding China 11 321 214 59 43 23 18 386
Leiming Wang China 11 274 0.9× 120 0.6× 61 1.0× 57 1.3× 22 1.0× 14 372
Guihong Zhang China 8 268 0.8× 238 1.1× 39 0.7× 30 0.7× 13 0.6× 13 347
Qiandong Zhu China 10 212 0.7× 168 0.8× 53 0.9× 45 1.0× 16 0.7× 14 309
Jingtao Luo China 9 227 0.7× 184 0.9× 66 1.1× 48 1.1× 10 0.4× 16 341
Zhenbing Lv China 12 373 1.2× 237 1.1× 66 1.1× 35 0.8× 24 1.0× 20 463
Zhigang Cao China 11 229 0.7× 151 0.7× 70 1.2× 39 0.9× 27 1.2× 35 331
Xiang Sun China 9 206 0.6× 137 0.6× 60 1.0× 39 0.9× 31 1.3× 13 302

Countries citing papers authored by Zongli Ding

Since Specialization
Citations

This map shows the geographic impact of Zongli Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zongli Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zongli Ding more than expected).

Fields of papers citing papers by Zongli Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zongli Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zongli Ding. The network helps show where Zongli Ding may publish in the future.

Co-authorship network of co-authors of Zongli Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Zongli Ding. A scholar is included among the top collaborators of Zongli Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zongli Ding. Zongli Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zhang, Jie, Wei Wang, Xiaoqing Wang, et al.. (2025). A robust diagnostic model for high-risk MASH: integrating clinical parameters and circulating biomarkers through a multi-omics approach. Hepatology International. 19(4). 820–835. 3 indexed citations
2.
Ye, Bicheng, Yuming Huang, Hui Gong, et al.. (2025). Machine learning identifies TIME subtypes linking EGFR mutations and immune states in lung adenocarcinoma. npj Digital Medicine. 8(1). 796–796.
3.
Ding, Yang, Dingli Wang, Dali Yan, et al.. (2025). Harnessing single-cell and multi-omics insights: STING pathway-based predictive signature for immunotherapy response in lung adenocarcinoma. Frontiers in Immunology. 16. 1575084–1575084. 1 indexed citations
4.
Chen, Jianhui, Qun Liu, Zongli Ding, et al.. (2021). LncRNA NEAT1 aggravates lipopolysaccharide‐induced acute lung injury by regulating the miR‐98‐5p/TLR4 axis. Journal of Biochemical and Molecular Toxicology. 35(12). e22927–e22927. 8 indexed citations
5.
Du, Wenwen, Zongli Ding, Yi Wang, et al.. (2021). HIF-1α promoted vasculogenic mimicry formation in lung adenocarcinoma through NRP1 upregulation in the hypoxic tumor microenvironment. Cell Death and Disease. 12(4). 394–394. 39 indexed citations
6.
Zhang, Jie, Y Gao, Yi Wang, et al.. (2020). A Novel Long Non-coding RNA, MSTRG.51053.2 Regulates Cisplatin Resistance by Sponging the miR-432-5p in Non-small Cell Lung Cancer Cells. Frontiers in Oncology. 10. 215–215. 31 indexed citations
7.
Zhang, Jie, et al.. (2019). Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer. Biomedicine & Pharmacotherapy. 117. 109058–109058. 20 indexed citations
8.
Zhang, Jie, Dong Li, Yueming Zhang, et al.. (2019). Integrative analysis of mRNA and miRNA expression profiles reveals seven potential diagnostic biomarkers for non‑small cell lung cancer. Oncology Reports. 43(1). 99–112. 23 indexed citations
9.
Ding, Zongli, Jianjie Zhu, Yuanyuan Zeng, et al.. (2019). The regulation of Neuropilin 1 expression by miR‐338‐3p promotes non‐small cell lung cancer via changes in EGFR signaling. Molecular Carcinogenesis. 58(6). 1019–1032. 26 indexed citations
10.
Ding, Zongli, Wenwen Du, Zhe Lei, et al.. (2019). Neuropilin 1 modulates TGF‑β1‑induced epithelial‑mesenchymal transition in non‑small cell lung cancer. International Journal of Oncology. 56(2). 531–543. 26 indexed citations
11.
Tang, Haicheng, Jianjie Zhu, Wenwen Du, et al.. (2018). CPNE1 is a target of miR-335-5p and plays an important role in the pathogenesis of non-small cell lung cancer. Journal of Experimental & Clinical Cancer Research. 37(1). 131–131. 58 indexed citations
12.
Tang, Haicheng, Jianjie Zhu, Yuanyuan Zeng, et al.. (2018). High expression of Copine�1 promotes cell growth and metastasis in human lung adenocarcinoma. International Journal of Oncology. 53(6). 2369–2378. 29 indexed citations
13.
Zeng, Yuanyuan, Jianjie Zhu, Hualong Qin, et al.. (2017). Methylated +322–327 CpG site decreases hOGG1 mRNA expression in non-small cell lung cancer. Oncology Reports. 38(1). 529–537. 3 indexed citations
14.
Li, Tao, Zongli Ding, Yulong Zheng, & Wei Wang. (2017). MiR-484 promotes non-small-cell lung cancer (NSCLC) progression through inhibiting Apaf-1 associated with the suppression of apoptosis. Biomedicine & Pharmacotherapy. 96. 153–164. 58 indexed citations
15.
Chen, Jianhui, Yulong Zheng, Zongli Ding, et al.. (2016). Valproic acid (VPA) enhances cisplatin sensitivity of non-small cell lung cancer cells via HDAC2 mediated down regulation of ABCA1. Biological Chemistry. 398(7). 785–792. 43 indexed citations
16.
Liu, Shu, et al.. (2014). A 2-DE-based proteomic study on the toxicological effects of cisplatin in L02 cells. Environmental Toxicology and Pharmacology. 39(1). 167–175. 1 indexed citations
17.
Wang, Wei, et al.. (2013). Dose responsive effects of cisplatin in L02 cells using NMR-based metabolomics. Environmental Toxicology and Pharmacology. 37(1). 150–157. 16 indexed citations
18.
Ding, Zongli, Lu Wang, Hong Zhu, et al.. (2012). [Effect of Akt on the function of esophageal squamous cancer cell Eca109 and the expression of vasculogenic mimicry-related genes].. PubMed. 92(36). 2556–60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026